Literature DB >> 7575633

Differential antiviral activity of derivatized dextrans.

J Neyts1, D Reymen, D Letourneur, J Jozefonvicz, D Schols, J Este, G Andrei, P McKenna, M Witvrouw, S Ikeda.   

Abstract

The antiviral activity of water-soluble dextrans derivatized with varying percentages of carboxymethyl, benzylamide, and sulfonate groups was evaluated. Several of the polymers exhibited potent antiviral activity against a variety of enveloped viruses, but not against non-enveloped viruses, and only when present during virus adsorption. The mechanism of activity against retroviruses [i.e. human immunodeficiency virus (HIV)] and herpes viruses (i.e. human cytomegalovirus) could be ascribed to inhibition of virus binding to the cells. An absolute requirement for anti-HSV activity appeared to be a sufficiently high percentage of benzylamide and benzylamide sulfonate groups. This did not, however, apply for human cytomegalovirus, respiratory syncytial virus, and HIV. The sensitivity of the latter viruses appeared to be influenced by factors other than the global chemical composition, which leads us to assume that physical factors such as the distribution and sequence of the substituents on the sugar backbone play an important role in the antiviral activity of the derivatized dextrans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575633     DOI: 10.1016/0006-2952(95)00193-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 2.  Receptor mimicry as novel therapeutic treatment for biothreat agents.

Authors:  Richard J Thomas
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

3.  Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.

Authors:  Roger G Ptak; Philippe A Gallay; Dirk Jochmans; Andrew P Halestrap; Urs T Ruegg; Luke A Pallansch; Michael D Bobardt; Marie-Pierre de Béthune; Johan Neyts; Erik De Clercq; Jean-Maurice Dumont; Pietro Scalfaro; Kamel Besseghir; Roland M Wenger; Brigitte Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

4.  Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.

Authors:  Roger Badia; Guillem Angulo; Eva Riveira-Muñoz; Maria Pujantell; Teresa Puig; Cristina Ramirez; Javier Torres-Torronteras; Ramón Martí; Eduardo Pauls; Bonaventura Clotet; Ester Ballana; José A Esté
Journal:  J Antimicrob Chemother       Date:  2015-11-04       Impact factor: 5.790

Review 5.  Polysaccharides and Their Derivatives as Potential Antiviral Molecules.

Authors:  Hadrien Claus-Desbonnet; Elsa Nikly; Vanya Nalbantova; Diana Karcheva-Bahchevanska; Stanislava Ivanova; Guillaume Pierre; Niko Benbassat; Plamen Katsarov; Philippe Michaud; Paolina Lukova; Cédric Delattre
Journal:  Viruses       Date:  2022-02-18       Impact factor: 5.048

6.  High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

Authors:  Sophia T Mundle; Hector Hernandez; John Hamberger; John Catalan; Changhong Zhou; Svetlana Stegalkina; Andrea Tiffany; Harry Kleanthous; Simon Delagrave; Stephen F Anderson
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

7.  Anti-viral activity of red microalgal polysaccharides against retroviruses.

Authors:  Marina M Talyshinsky; Yelena Y Souprun; Mahmoud M Huleihel
Journal:  Cancer Cell Int       Date:  2002-07-05       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.